Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
121.50    0.00 (0.00%)
Bid:
120.00
Ask:
122.00
Spread: 2.00 (1.667%)
Market Cap: £95.35m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Period end trading update

21 Jan 2010 07:00

RNS Number : 8908F
Xaar PLC
21 January 2010
 



FOR IMMEDIATE RELEASE

21 January 2010

Xaar plc

FULL YEAR TRADING UPDATE

Xaar plc ("Xaar"), the inkjet printing technology group headquartered in Cambridge, presents an update on trading performance for the year ended 31 December 2009.

Trading

Trading for the fourth quarter of 2009 and the year as a whole was in line with the Board's expectations and the financial results for the 12 months ended 31 December 2009 are expected to be in line with market expectations.

The trends reported in the IMS dated 14 October 2009 continued through to the year-end. OEM customers are continuing to develop digital printing machines incorporating Xaar's Platform 3 technology and, whilst some applications are now technically proven and contribute material revenue to Xaar, others still remain some way from full commercialisation. Xaar remains committed to providing its Platform 3 customers with the necessary support to bring these developments to a successful conclusion and has continued to incur some significant costs in doing this.

Sales of Platform 1 products continue to deliver the majority of Xaar's revenues through both new product launches and continuing sales of existing products, albeit at lower margins than seen historically. These lower margins are a direct result of the highly competitive nature of this market and, as is the case for Platform 3, higher than expected customer support costs for some of these products.

The project to transfer those manufacturing facilities located in Sweden to the Group's Huntingdon facility continues to be on track with completion scheduled for March 2011.

Whilst results for 2009 are expected to be in line with market consensus, the level of profitability reflected the benefits of the cost cutting programme previously implemented offset by the higher than anticipated product and customer support costs. The Board is continuing to take appropriate action to improve profitability and is planning on delivering improved results for 2010.

Cash

Net cash and cash equivalents at 31 December 2009 were approximately £11.1m (31 December 2008: £11.0m, 30 June 2009: £10.3m) after payment of £1.5dividends in the year.

Dividend

It is the Board's intention to recommend the payment of a final dividend, details of which will be provided at the time of the announcement of the final results for the year.

Announcement of final results

The detailed results for 2009 will be announced in accordance with Xaar's normal timetable on 17 March 2010.

Ends

CONTACTS

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director 

 

 

 

Singer Capital Markets Limited:

020-3205-7626

Shaun Dobson

 

 

 

Bankside Consultants:

 

Steve Liebmann

020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEFEFSFSSEEF
Date   Source Headline
1st Jul 20221:10 pmRNSTotal Voting Rights
21st Jun 20225:20 pmRNSDirector Declaration - Additional Directorship
1st Jun 202210:22 amRNSTotal Voting Rights
25th May 20221:57 pmRNSResult of AGM
3rd May 20225:20 pmRNSTotal Voting Rights
7th Apr 20226:31 pmRNSPDMR Shareholding
7th Apr 20222:50 pmRNSGrant of Options and Deferred Bonus Share Awards
1st Apr 202210:48 amRNSTotal Voting Rights
29th Mar 20227:00 amRNS2021 Full Year Results
28th Mar 202210:44 amRNSHolding(s) in Company
21st Mar 202212:37 pmRNSNotice of 2021 Preliminary Results
3rd Mar 20227:00 amRNSAcquisition of Megnajet
1st Mar 20225:29 pmRNSTotal Voting Rights
1st Feb 20225:00 pmRNSTotal Voting Rights
18th Jan 20224:35 pmRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSTrading Update
4th Jan 20222:39 pmRNSBlock listing Interim Review
4th Jan 20222:37 pmRNSTotal Voting Rights
10th Dec 20214:23 pmRNSGrant of Awards - Replacement
6th Dec 202112:25 pmRNSHolding(s) in Company
1st Dec 20215:00 pmRNSTotal Voting Rights
5th Nov 202110:30 amRNSGrant of Sharesave Options
1st Nov 20214:11 pmRNSCompletion of Divestment of Xaar 3D
1st Nov 20211:56 pmRNSTotal Voting Rights
29th Oct 20214:41 pmRNSSecond Price Monitoring Extn
29th Oct 20214:36 pmRNSPrice Monitoring Extension
25th Oct 202110:38 amRNSResult of General Meeting
15th Oct 202111:50 amRNSGrant of Options and Deferred Bonus Share Awards
14th Oct 20218:44 amRNSBlock Listing Application
13th Oct 20212:52 pmRNSHolding(s) in Company
6th Oct 20212:43 pmRNSPublication of Circular and Notice of GM
6th Oct 20217:00 amRNSProposed divestment of Xaar 3D
1st Oct 202111:59 amRNSTotal Voting Rights
14th Sep 20217:00 amRNS2021 Interim Results
3rd Sep 202112:59 pmRNSNotice of 2021 Interim Results
2nd Sep 20213:40 pmRNSTotal Voting Rights
2nd Aug 20215:02 pmRNSTotal Voting Rights
22nd Jul 20217:00 amRNSTrading Update
12th Jul 20217:00 amRNSAcquisition of FFEI
1st Jul 20213:20 pmRNSBlock listing Interim Review
1st Jul 202110:51 amRNSTotal Voting Rights
22nd Jun 20215:37 pmRNSHolding(s) in Company
22nd Jun 202111:44 amRNSHolding(s) in Company
16th Jun 20211:17 pmRNSResult of AGM
1st Jun 202110:10 amRNSTotal Voting Rights
17th May 20219:27 amRNSHolding(s) in Company
12th May 202110:15 amRNSHolding(s) in Company
4th May 20213:01 pmRNSTotal Voting Rights
30th Apr 20216:23 pmRNSAnnual Financial Report
27th Apr 20217:00 amRNS2020 FULL YEAR RESULTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.